Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
About this item
Full title
Author / Creator
Kanes, Stephen, MD , Colquhoun, Helen, MD , Gunduz-Bruce, Handan, MD , Raines, Shane , Arnold, Ryan, DO , Schacterle, Amy, PhD , Doherty, James, PhD , Epperson, C Neill, Prof , Deligiannidis, Kristina M, MD , Riesenberg, Robert, MD , Hoffmann, Ethan , Rubinow, David, Prof , Jonas, Jeffrey, MD , Paul, Steven, MD and Meltzer-Brody, Samantha, Dr
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Post-partum depression is a serious mood disorder in women that might be triggered by peripartum fluctuations in reproductive hormones. This phase 2 study investigated brexanolone (USAN; formerly SAGE-547 injection), an intravenous formulation of allopregnanolone, a positive allosteric modulator of γ-aminobutyric acid (GABAA ) re...
Alternative Titles
Full title
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
Authors, Artists and Contributors
Author / Creator
Colquhoun, Helen, MD
Gunduz-Bruce, Handan, MD
Raines, Shane
Arnold, Ryan, DO
Schacterle, Amy, PhD
Doherty, James, PhD
Epperson, C Neill, Prof
Deligiannidis, Kristina M, MD
Riesenberg, Robert, MD
Hoffmann, Ethan
Rubinow, David, Prof
Jonas, Jeffrey, MD
Paul, Steven, MD
Meltzer-Brody, Samantha, Dr
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1910792646
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1910792646
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(17)31264-3
